Court orders Prevagen to cease memory-improvement claims
Quincy Bioscience, the dietary supplement maker, must stop making specific advertising claims deemed deceptive.
Quincy Bioscience, the dietary supplement maker, must stop making specific advertising claims deemed deceptive.
Kellanova's predictions highlight opportunities amid disruption and emphasize the potential for the CPG sector to thrive in a dynamic, technology-driven marketplace.
The Advisory Committee's scientific report revealed troubling trends: Americans’ diets consistently fall short of aligning with Dietary Guidelines recommendations, leading to increased risk of nutrient inadequacies.
The new members bring a wealth of expertise and resources, reinforcing CHPA's mission.
Cheerios Protein delivers part of a nutritionally balanced breakfast with 8 grams of protein per serving.
Eva NYC announces a brand renovation focused on clinically proven haircare and sustainability, featuring eco-conscious packaging and innovative product formulations.
Nestlé’s Vital Pursuit is transforming frozen pizza with its Max Pro line, which launches this January and features unmatched protein and fiber content.
Pricing and access to drugs and medical devices seen as the most significant issue facing the life sciences industry.
Michael Del Pozzo, president of the U.S. Confection unit, is departing the company effective December 12.
Creativity helps children express themselves, fostering problem-solving and achievement.
Bask Health's telehealth platform seamlessly connects patients to licensed providers specializing in GLP-1 medications like semaglutide and liraglutide.
The kit includes fan-favorite candy from NERDS, SweeTARTS, Trolli, and BRACH'S; a jar for mixing and other festive surprises, perfect for sweet gifting.
Kathryn Healy is director of brand management at Dr. Reddy’s Laboratories and part of the company’s Self Care and Wellness team.
Strategy reflects Cencora’s commitment to meet customers’ evolving needs.
While we share lawmakers’ commitment to promoting consumer safety, we believe the proposed legislation takes an overly broad approach that could inadvertently impact legitimate dietary supplements without addressing the root causes of public health concerns.
The agreement has been in place since 2019 and has scored a major new product launch success in delivering a biosimilar product into the Japanese market. This biosimilar is used with cancer medicines.